Thursday, November 24, 2016

Free Trial Request

Free Trial Request

 Free Trial Request


Thursday, November 10, 2016

Call For Paper

Bentham Science Publishers would like to invite you to submit your research paper for publishing in the Journal of 


Thursday, November 3, 2016

Highlighted Artcile: The Disulfide Analogues of Isophosphoramide Mustard for Anticancer Therapy

The Disulfide Analogues of Isophosphoramide Mustard for Anticancer Therapy


Joanna Cytarska, Krzysztof Skowerski, Szymon Jaworski, Konrad Misiura, Beata Filip-Psurska and Joanna Wietrzyk   Pages 172 - 179 ( 8 )


Novel disulfide analogues of isophosphoramide mustard (iPAM) were designed and synthesised. All compounds were hydrolytically stable and underwent reduction by L-glutathione with different kinetic parameters. Based on the HPLC-MS analysis a mechanism of activation by glutathione obtained disulfide analogues of iPAM was proposed. The compounds were tested for cytotoxic activity against human promyelocytic leukaemia HL-60, human lymphoblastic leukaemia MOLT-4, human lymphoblastic leukaemia CCRF/CEM, human bladder cancer HCV29T, murine melanoma B16-F0 and murine fibroblasts Balb3T3 cell lines. The most promising anticancer activity was exhibited by compound 4, which proved to be more active than the reference cisplatin against all cancer cell lines.


Anticancer activity, disulfide, glutathione, isophosphoramide mustard.


Department of Chemical Technology and Pharmaceuticals, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Jurasza 2, 85-089 Bydgoszcz, Poland.

Graphical Abstract:

For More Information Please Visit Our Website Current Letter in Drug Design & Discovery